Compare StocksEXPD vs PFE

Expeditors International of Washington, Inc. (EXPD) vs Pfizer Inc. (PFE): Which Is the Better Buy in 2026?

As of 2026-06-19, EXPD is overvalued at $161, with a DCF intrinsic value of $101 and a margin of safety of -60%. PFE is overvalued at $25, with an intrinsic value of $22 and a margin of safety of -12%. Of the two, PFE has the wider margin of safety.

EXPD
Expeditors International of Washington, Inc.
$161.32
VS
PFE
Pfizer Inc.
$25.21

Rewards

EXPD
  • Expeditors International of Washington, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Return on equity has consistently exceeded 20% over 4 years, indicating efficient use of shareholder capital.
  • Share count has been reduced by 13% over the past 4 years through buybacks, increasing each share's claim on earnings.
PFE
  • Gross margin of 74.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • FCF yield of 8.6% is historically attractive — the business generates significant cash relative to its price.
  • Trailing P/E of 19.2x is 37% below the historical average of 30.4x — potentially undervalued relative to its own history.

Risks

EXPD
  • Gross margin of 13.6% is low, suggesting a competitive or commodity-like market with limited pricing power.
  • Trailing P/E of 26.1x is 28% above the historical average of 20.5x — the stock trades at a premium to its own history.
  • PEG ratio of 3.77 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
PFE
  • ROIC has declined by 15.9 percentage points over the past 4 years, which may signal competitive erosion.
  • PEG ratio of 13.77 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Free cash flow has declined at a 29.6% CAGR over the past 4 years — a concerning trend.

Key Valuation Metrics

Learn more →
EXPD
PFE
Valuation
$783.25M
Free Cash Flow
$12.38B
3.71%
FCF Yield
8.61%
26.10
Trailing P/E
19.24
23.65
Forward P/E
8.91
Quality & Moat
32.83%
ROIC
10.19%
36.64%
ROE
8.31%
13.62%
Gross Margin
74.80%
3.77
PEG Ratio
13.77
Balance Sheet Safety
Net cash
Net Debt / Equity
0.57
N/A
Interest Coverage
N/A
-0.66
Net Debt / EBITDA
2.03
0.99%
Dividend Yield
6.61%
EXPD: 5Ties: 1PFE: 6
EXPDPFE

Historical Fundamentals

Learn more →
EXPD

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

PFE

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
EXPD
$2.22
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$1.76B
Δ Market Cap
+$3.91B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
PFE
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-10.61B
Δ Market Cap
$-146.18B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
EXPD
59.7% Overvalued
Price is 59.7% above estimated fair value
Current Price: $161.32
Fair Value: $101.02
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
PFE
12.3% Overvalued
Price is 12.3% above estimated fair value
Current Price: $25.21
Fair Value: $22.46
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
EXPD

What growth rate is the market pricing in at $161?

+10.7%
Market-Implied Owner Earnings Growth
Standard FCF implies +11.3%

The market implies +10.7% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +11.3%, reflecting heavy growth investment.

PFE

What growth rate is the market pricing in at $25?

+5.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +4.5%

The market implies +5.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +4.5%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
EXPD
69/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with margin stability as the key competitive advantage. Improving revenue predictability would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
PFE
35/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
EXPD
-2.55
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
PFE
-2.53
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
EXPD
Insiders 0.6%Institutions 101.0%
No. of Institutional Holders1,297
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
PFE
Insiders 0.1%Institutions 69.4%Retail & Other 30.5%
No. of Institutional Holders3,744
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
EXPD
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
PFE
0
Buys (3M)
0
Buys (12M)
BLAYLOCK RONALD E
Director
$499,072
@ $25.65 · 2025-02-13
GOTTLIEB SCOTT
Director
$28,240
@ $28.24 · 2024-10-30
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
EXPD
0
Sells (3M)
8
Sells (12M)
Total value (12M): $6.40M
WALL DANIEL R.
Chief Executive Officer
$884,927
@ $145.07 · 2026-02-27
BELL BLAKE R
Officer
$1.49M
@ $144.08 · 2026-02-27
EMMERT MARK A
Director
$730,350
@ $135.25 · 2025-11-07
DICKERMAN JEFFREY F
General Counsel
$201,255
@ $134.17 · 2025-11-05
CARLILE ROBERT PAUL
Director
$301,268
@ $120.51 · 2025-09-05
EMMERT MARK A
Director
$497,150
@ $121.26 · 2025-08-19
DICKERMAN JEFFREY F
General Counsel
$173,535
@ $118.05 · 2025-08-07
BELL BLAKE R
Officer
$2.12M
@ $117.89 · 2025-08-06
WALL DANIEL R.
Chief Executive Officer
$1.16M
@ $115.91 · 2025-05-12
DICKERMAN JEFFREY F
General Counsel
$146,923
@ $117.54 · 2025-02-20
CARLILE ROBERT PAUL
Director
$363,332
@ $121.11 · 2024-12-10
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
PFE
1
Sells (3M)
1
Sells (12M)
Total value (12M): $51,400
DAMICO JENNIFER B.
Officer
$51,400
@ $25.70 · 2026-06-09
DAMICO JENNIFER B.
Officer
$64,825
@ $25.93 · 2025-03-04
DAMICO JENNIFER B.
Officer
$147,714
@ $28.66 · 2024-08-13
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
EXPD
FearGreed
😏Greed(64/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
PFE
FearGreed
😐Neutral(49/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
EXPD
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (64)
PFE
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (49)
View EXPD Full AnalysisView PFE Full Analysis

Frequently Asked Questions: EXPD vs PFE

Is Expeditors International of Washington, Inc. or Pfizer Inc. more undervalued in 2026?

Based on our discounted cash flow model, PFE trades at a -12.3% margin of safety (intrinsic value $22 vs. price $25), compared to EXPD's -59.7% margin of safety (intrinsic $101 vs. $161).

Which stock has a wider economic moat, Expeditors International of Washington, Inc. or Pfizer Inc.?

EXPD scores 69/100 (Narrow moat), while PFE scores 35/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Pfizer Inc. in financial distress?

PFE's Altman Z-Score of 2.1 places it in the Grey zone, signaling elevated bankruptcy risk. EXPD scores 8.8 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, Expeditors International of Washington, Inc. or Pfizer Inc.?

Pfizer Inc. (PFE) generates a 8.6% free cash flow yield, compared to Expeditors International of Washington, Inc.'s 3.7%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Expeditors International of Washington, Inc. or Pfizer Inc.?

EXPD earns 32.8% ROIC versus PFE's 10.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Expeditors International of Washington, Inc.'s or Pfizer Inc.'s?

EXPD's dividend earns a safety score of 94/100 (Very Safe), compared to PFE's 24/100 (Unsafe). EXPD has raised its dividend for 3 consecutive years.